NONINVASIVE SCLEROSED GLOMERULE COUNT PROCEDURE IN HAEMORRHAGIC NEPHROSONEPHRITIS Russian patent published in 2009 - IPC A61B8/00 G01N33/48 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to nephrology and can be used for sclerosed glomerule count in haemorrhagic nephrosonephritis. The ratio of total natural logarithms of following indices is calculated including: ultrasound-aided averaged renal volume, cm³ (V_sr), as total renal volume divided by 2 (V_s+V_d)/2; hyaline casts count per mm² of a cytologic section (D); number of burned-out and necrotic tubule epithelium per 1 mm² of a cytologic section (D). Duration of acute renal failure, days (T), to total natural logarithms of glomerular filtration rate, ml/min (GFR) and averaged linear blood velocity in both basilar renal arteries (Vave_sr) as (V_aves+V_aved/2), cm/sec. Then the glomerular sclerosis index (GSI) is calculated by formula: If the GSI exceeds 1.5, glomerular sclerosis is considered to develop, while the GSI less than 1.5 shows the absence of glomerular sclerosis in haemorrhagic nephrosonephritis.

EFFECT: method provides ease of examination with reduced number of nephrobiopsies in the present disease.

1 tbl, 3 ex